UNSPSC 51285309: Furaltadone hydrochloride

This classification denotes an anti-infective agent with the molecular formula C13H16N4O6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 37Q02H7JT2, chemically known as 2-oxazolidinone, 5-(morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-, monohydrochloride but more generally known as furaltadone hydrochloride, which bears US NIH Compound Identifier 92968. European Medicines Agency schedules Furaltadone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02285MIG.

Most nations schedule furaltadone hydrochloride under HS 29349990. As of Q4 2014, FURALTADONE HYDROCHLORIDE remains the US FDA Preferred Term for this commodity. SMILES: C1CC(OC1/C=N/N2CC(OC2=O)CN3CCOCC3)[N+](=O)[O-].CL.

UNSPSC 51285309 Furaltadone hydrochloride is a Commodity code that covers specialty pharmaceutical products, though the recent state and local opportunities tagged under it show minimal direct alignment with the code's nominal scope. The Illinois Department of Public Health and Seminole County, Florida have posted procurement activity under this code in recent months, but the actual products being solicited—Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets in one case, Naloxone and drug deactivation systems in the other—fall outside furaltadone's therapeutic class and intended use. State and local health departments and county government entities drive demand when this code is used, typically for pharmaceutical warehousing, emergency medical supplies, and community health initiatives delivered through piggyback contracts or competitive bidding processes.

The geographic spread remains narrow based on recent activity, with Illinois and Florida accounting for the posted opportunities. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets, with a total award value of $2,999,999.11 over 12 months with two renewal options, selected through an Invitation for Bid process. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, a two-year initial term with one-year renewal option, and a response deadline of July 26, 2023. The code shows little relevant recent activity relative to its stated pharmaceutical scope, and the mismatch between the code designation and the products actually being procured suggests either data entry misclassification or evolving use of the code that diverges from its intended commodity definition.